Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LIFECORE BIOMEDICAL, INC. \DE\
Report date May 23, 2019 · Filed May 31, 2019 · Amendment
Section 16 reporting ended · disclosed 2019-05-31. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,137 |
Reported balance
After 2019-05-23 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-05-23 · Exercise / conversion · Acquired 4,240 · Balance 73,137 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2019-05-23 | Direct | 0 |
Reported balance
After 2019-05-23 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2019-05-23 · Exercise / conversion · Disposed 4,240 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on May 30, 2018. F3: The restricted stock units vested on May 23, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on May 30, 2018.
F3: The restricted stock units vested on May 23, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2019 Filed May 28, 2019 17:12 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007230 · wf-form4_155906350515522.xml · derivative · entry 2 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,240 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 30, 2018. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2019. Read SEC document |
| May 23, 2019 Filed May 28, 2019 17:12 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007230 · wf-form4_155906350515522.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2019 Filed May 31, 2019 00:40 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007416 · wf-form4a_155926321953260.xml · derivative · entry 2 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,240 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 30, 2018. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2019. Read SEC document |
| May 23, 2019 Filed May 31, 2019 00:40 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,240 | $9.35 | $39,644.00 |
DisclosureSEC source: 0001628280-19-007416 · wf-form4a_155926321953260.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 01:58 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0001437749-19-003666 · rdgdoc.xml · derivative · entry 3 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 01:58 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,593 | $12.84 | $33,294.12 |
DisclosureSEC source: 0001437749-19-003666 · rdgdoc.xml · nonDerivative · entry 2 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,897 Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 01:58 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $6.66 | $33,300.00 |
DisclosureSEC source: 0001437749-19-003666 · rdgdoc.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 19:00 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | PurchaseCommon Stock | 20,000 | $11.24 | $224,800.00 |
DisclosureSEC source: 0001437749-19-000633 · rdgdoc.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,490 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.80 to $11.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 21:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-011100 · rdgdoc.xml · derivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,240 Underlying: Common Stock · 4,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:38 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010773 · rdgdoc.xml · derivative · entry 2 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,286 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2017. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:38 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,286 | $13.65 | $58,503.90 |
DisclosureSEC source: 0001437749-18-010773 · rdgdoc.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 20:28 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.77 | $0.00 |
DisclosureSEC source: 0001437749-18-003431 · rdgdoc.xml · derivative · entry 3 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 20:28 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,169 | $13.30 | $28,847.70 |
DisclosureSEC source: 0001437749-18-003431 · rdgdoc.xml · nonDerivative · entry 2 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,204 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 20:28 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $5.77 | $28,850.00 |
DisclosureSEC source: 0001437749-18-003431 · rdgdoc.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:22 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-010671 · rdgdoc.xml · derivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Underlying: Common Stock · 4,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-010191 · rdgdoc.xml · derivative · entry 2 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,282 shares Expires 2017-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 25, 2016. F3 · derivative.exercise_date: The restricted stock units vested on May 25, 2017. F3 · derivative.expiration_date: The restricted stock units vested on May 25, 2017. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,282 | $13.50 | $71,307.00 |
DisclosureSEC source: 0001437749-17-010191 · rdgdoc.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 23, 2017 Filed May 24, 2017 19:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001437749-17-009977 · rdgdoc.xml · derivative · entry 3 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2017-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 24, 2017 19:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,100 | $13.40 | $28,140.00 |
DisclosureSEC source: 0001437749-17-009977 · rdgdoc.xml · nonDerivative · entry 2 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,091 Read SEC document |
| May 23, 2017 Filed May 24, 2017 19:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $5.63 | $28,150.00 |
DisclosureSEC source: 0001437749-17-009977 · rdgdoc.xml · nonDerivative · entry 1 GOLDBY STEVEN D · CIK 0001216626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.